Screener
Organogenesis Holdings Inc. ORGO Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Organogenesis Holdings Inc.’s reported figures.
The source filing: Organogenesis Holdings Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338049
FAQ
- What is Organogenesis Holdings Inc.'s invested capital?
- Organogenesis Holdings Inc. (ORGO) reported invested capital of $138.74M in Q2 2026.
- How has Organogenesis Holdings Inc.'s invested capital changed year-over-year?
- Organogenesis Holdings Inc.'s invested capital decreased by 27.3% year-over-year, from $190.84M to $138.74M.
- What is the long-term trend for Organogenesis Holdings Inc.'s invested capital?
- Over 5 years (2020 to 2025), Organogenesis Holdings Inc.'s invested capital has grown at a 17.1% compound annual growth rate (CAGR), from $135.07M to $298.02M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Organogenesis Holdings Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude